Showing results (61-70 of 158) with videos related to

Sort By:
Pageof 16
American Journal of Clinical Oncology|November 3, 2015
Successful Ifosfamide Rechallenge in Soft-Tissue SarcomaJonathan Noujaim, Anastasia Constantinidou, Christina Messiou, et al.
Expert Review of Anticancer Therapy|November 1, 2019
The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanibChristopher P Wilding, Mark L Elms, Ian Judson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Phase I trial of ZD9331, a nonpolyglutamatable thymidylate synthase inhibitor, given as a 5-day continuous infusion to patients with refractory solid malignanciesCharlotte Rees, P Beale, Jose Manuel Trigo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Prospective validation of a prognostic score to improve patient selection for oncology phase I trialsHendrik-Tobias Arkenau, Jorge Barriuso, David Olmos, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2008
Identification of factors limiting patient recruitment into phase I trials: a study from the Royal Marsden HospitalVasilios Karavasilis, Laurence Digue, Tobias Arkenau, et al.
Cancer Chemotherapy and Pharmacology|December 24, 2002
A study to evaluate the pharmacokinetics of oral 5-fluorouracil and eniluracil after concurrent administration to patients with refractory solid tumours and varying degrees of renal impairment (FUMA1005)Anne O'Donnell, Cornelis J A Punt, Ian Judson, et al.
British Journal of Cancer|June 5, 2024
Gastrointestinal stromal tumour (GIST): British Sarcoma Group clinical practice guidelinesIan Judson, Robin L Jones, Newton A C S Wong, et al.
Clinical Sarcoma Research|May 6, 2016
UK guidelines for the management of bone sarcomasCraig Gerrand, Nick Athanasou, Bernadette Brennan, et al.
Sarcoma|January 22, 2011
UK Guidelines for the Management of Bone SarcomasRobert Grimer, Nick Athanasou, Craig Gerrand, et al.
Journal of Gastroenterology and Hepatology|April 3, 2016
Short bowel syndrome (SBS)-associated alterations within the gut-liver axis evolve early and persist long-term in the piglet model of short bowel syndromePrue M Pereira-Fantini, Julie E Bines, Susan Lapthorne, et al.
Pageof 16